Cancer and mTOR inhibitors in kidney transplantation recipients

Background Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. Methods In the current study, patients were registered into...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chih-Chin Kao, Jia-Sin Liu, Yu-Kang Chang, Ming-Huang Lin, Yen-Chung Lin, Hsi-Hsien Chen, Wei-Chiao Chang, Chih-Cheng Hsu, Mai-Szu Wu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: PeerJ Inc. 2018-11-01
Saila:PeerJ
Gaiak:
Chronic kidney disease
Cancer
Kidney transplantation
Mortality
mTOR inhibitors
Sarrera elektronikoa:https://peerj.com/articles/5864.pdf
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak